(VIANEWS) - Fanhua (FANH), ChipMOS TECHNOLOGIES (IMOS), BlackRock Floating Rate Income Trust (BGT) have the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Fanhua (FANH) | 4.45 | -4.3% | 12.9% | 2022-06-14 03:06:14 |
| 2 | ChipMOS TECHNOLOGIES (IMOS) | 34.10 | -1.84% | 8.52% | 2022-06-09 07:13:05 |
| 3 | BlackRock Floating Rate Income Trust (BGT) | 11.43 | -0.35% | 6.77% | 2022-06-01 19:07:06 |
| 4 | National Health Investors (NHI) | 59.20 | 0.44% | 6.11% | 2022-06-04 13:42:06 |
| 5 | Crown Crafts (CRWS) | 6.54 | 0.77% | 5.3% | 2022-06-07 19:09:49 |
| 6 | Gilead Sciences (GILD) | 58.42 | 1.08% | 4.68% | 2022-06-15 14:58:27 |
| 7 | Invesco (IVZ) | 16.44 | 1.23% | 4.2% | 2022-06-15 14:59:14 |
| 8 | Radian Group (RDN) | 21.10 | -1.17% | 3.78% | 2022-06-05 03:19:14 |
| 9 | Consolidated Water Co. Ltd. (CWCO) | 14.34 | 0.21% | 2.97% | 2022-06-07 21:14:14 |
| 10 | QUALCOMM (QCOM) | 130.79 | 0.41% | 2.22% | 2022-06-15 14:58:59 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Fanhua (FANH) - Dividend Yield: 12.9%
Fanhua Inc. and its subsidiary distribute insurance products in China. The company operates in two distinct segments: Insurance Agency and Claims Adjusting. Insurance Agency provides property- and casualty insurance products. These products include travel insurance, homeowners insurance, indemnity insurance, and insurance products for individual accidents. Life insurance products such as life insurance, including individual annuity and individual whole lives, individual term life, individual life expectancy, and individual life. Pre-underwriting surveys, claims adjusting and residual value disposal are all part of the Claims Adjusting segment. They also provide loading and unloading supervision and consulting services. Baoxian.com is an online platform that allows users to find, purchase, and search for insurance products. Lan Zhanggui is an all-in-one internet application. ehuzhu.com and CNpad Auto are online platforms for mutual assistance and facilitating insurance transactions. Customers can be served by the company's insurance service and sales group as well as insurance agencies and sales and service branches, independent agents registered and claims adjustors. The former name of the company was CNinsure Inc., but it changed its name in December 2016 to Fanhua Inc. Fanhua Inc. is located in Guangzhou in China. It was established in 1998.
Volume
Today's last reported volume for Fanhua is 37604, 64.53% below its average volume of 106029.
Fanhua's last close was $4.45, 72.19% below its 52-week high of $16.00.
Fanhua's Revenue
Year-on-year quarterly revenue growth declined by 37.3%, now sitting on 2.86B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Fanhua's stock is considered to be overbought (>=80).
Fanhua's Stock Yearly Top and Bottom Value
Fanhua's stock is valued at $4.45 at 17:15 EST, way below its 52-week high of $16.00 and above its 52-week low of $4.35.
Fanhua's Moving Average
Fanhua's worth is way under its 50-day moving average of $6.03 and way under its 200-day moving average of $9.06.More news about Fanhua.
2. ChipMOS TECHNOLOGIES (IMOS) - Dividend Yield: 8.52%
The company ChipMOS TECHNOLOGIES INC. develops and manufactures integrated circuits with high-integration, high-precision, and other related services. They also offer testing and assembly services throughout Taiwan, Japan and Singapore. It operates in three segments: Testing, Assembly; Testing for OLED Display Panel Driver Semiconductors and Bumping; as well as Other. The company offers a variety of test and back-end assembly services including wafer probing and engineering tests for memory/logic/mixed signal semiconductors. It also provides leadframe and organic substrate-based assembly services for both memory/mixed signal and leadframe- and organic substrate-based packages for these semiconductors. Its semiconductors can be found in graphics equipment, personal computers, communications equipment, mobile devices comprising cell phones, tablets and consumer electronics, as well as automotive/industry and displays applications such as panels. ChipMOS TECHNOLOGIES INC. is a Taiwanese company that was founded in 1997. Its headquarters are in Hsinchu.
Volume
Today's last reported volume for ChipMOS TECHNOLOGIES is 14923, 20.03% below its average volume of 18661.
ChipMOS TECHNOLOGIES's last close was $34.10, 23.75% below its 52-week high of $44.72.
ChipMOS TECHNOLOGIES's Revenue
Year-on-year quarterly revenue growth grew by 4%, now sitting on 27.66B for the twelve trailing months.
ChipMOS TECHNOLOGIES's Stock Yearly Top and Bottom Value
ChipMOS TECHNOLOGIES's stock is valued at $34.10 at 17:15 EST, way under its 52-week high of $44.72 and way higher than its 52-week low of $30.10.
ChipMOS TECHNOLOGIES's Moving Average
ChipMOS TECHNOLOGIES's worth is above its 50-day moving average of $32.98 and below its 200-day moving average of $34.49.More news about ChipMOS TECHNOLOGIES.
3. BlackRock Floating Rate Income Trust (BGT) - Dividend Yield: 6.77%
BlackRock Floating Rate Income Trust, a closed-ended fixed income mutual fund that was launched in 2012 by BlackRoack Inc. BlackRock Advisors, LLC, and BlackRock Financial Management, Inc. co-manage the fund. The fund invests in fixed income markets around the world, with a focus on the United States. It invests in bonds issued by companies that operate across diverse sectors. The fund invests in corporate bonds whose average duration will not exceed 1.5 years. The former name of the fund was BlackRock GlobalFloating Rate Income trust. BlackRock Floating Rate Income Trust, which was established on August 30, 2004, is based in the United States.
Volume
Today's last reported volume for BlackRock Floating Rate Income Trust is 33809, 65.66% below its average volume of 98442.
BlackRock Floating Rate Income Trust's last close was $11.43, 22.46% under its 52-week high of $14.74.
BlackRock Floating Rate Income Trust's Revenue
Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 19.49M for the twelve trailing months.
BlackRock Floating Rate Income Trust's Stock Yearly Top and Bottom Value
BlackRock Floating Rate Income Trust's stock is valued at $11.43 at 17:15 EST, way below its 52-week high of $14.74 and higher than its 52-week low of $10.98.
BlackRock Floating Rate Income Trust's Moving Average
BlackRock Floating Rate Income Trust's value is below its 50-day moving average of $11.99 and way below its 200-day moving average of $13.05.More news about BlackRock Floating Rate Income Trust.
4. National Health Investors (NHI) - Dividend Yield: 6.11%
National Health Investors, Inc. was founded in 1991. It is a real-estate investment trust that specializes in the sale-leaseback, joint venture, mortgage, mezzanine, and mortgage financing of senior housing, as well as medical investments. NHI has a portfolio that includes independent, assisted, and memory care communities as well as entrance-fee retirement communities and skilled nursing facilities. It also owns medical office buildings, specialty hospitals, and medical office buildings.
Volume
Today's last reported volume for National Health Investors is 251598, 5.88% below its average volume of 267322.
National Health Investors's last close was $59.20, 14.49% under its 52-week high of $69.23.
The company's growth estimates for the current quarter is a negative 14.1% and positive 7.5% for the next.National Health Investors's Revenue
Year-on-year quarterly revenue growth declined by 10.6%, now sitting on 288.45M for the twelve trailing months.
National Health Investors's Stock Yearly Top and Bottom Value
National Health Investors's stock is valued at $59.20 at 17:15 EST, way under its 52-week high of $69.23 and way above its 52-week low of $50.22.
National Health Investors's Moving Average
National Health Investors's value is higher than its 50-day moving average of $56.01 and above its 200-day moving average of $56.32.More news about National Health Investors.
5. Crown Crafts (CRWS) - Dividend Yield: 5.3%
Crown Crafts, Inc., and its subsidiaries, operate in the United States' consumer goods industry. The company offers infant, toddler and juvenile products. These include blankets and swaddle sheets, nursery accessories, room dA(c), and burp cloths. It also sells disposable and reusable placemats. Through a sales network and independent commissioned representatives, the company's products are sold primarily to mid-tier and high-end retailers as well as juvenile specialty and value stores, supermarket and drug shops, and grocery and drug stores. Crown Crafts, Inc., was founded in 1957. It is located in Gonzales, Louisiana.
Volume
Today's last reported volume for Crown Crafts is 11156, 23.95% below its average volume of 14669.
Crown Crafts's last close was $6.54, 20.73% under its 52-week high of $8.25.
Crown Crafts's Sales
Crown Crafts's sales growth is a negative 0.6% for the current quarter and a decline by 1.7% for the next.
Crown Crafts's Revenue
Year-on-year quarterly revenue growth grew by 16.8%, now sitting on 83.5M for the twelve trailing months.
Crown Crafts's Stock Yearly Top and Bottom Value
Crown Crafts's stock is valued at $6.54 at 17:15 EST, way under its 52-week high of $8.25 and above its 52-week low of $5.95.
Crown Crafts's Moving Average
Crown Crafts's value is higher than its 50-day moving average of $6.25 and below its 200-day moving average of $6.95.More news about Crown Crafts.
6. Gilead Sciences (GILD) - Dividend Yield: 4.68%
Gilead Sciences, Inc. is a biopharmaceutical company that is research-based. It discovers, develops, commercializes and markets medicines in areas with unmet medical need in the United States, Europe, as well internationally. Biktarvy and Descovy are among the company's products. They also offer Truvada, Complera/Eviplera and Truvada to treat human immunodeficiency viruses (HIV). Yescarta is a chimeric antigen receptor therapy T cell treatment for adults with relapsed large-cell lymphoma. Zydelig is a kinase inhibitor. Letairis, an oral formulation for an endothelin antagonist, treats pulmonary arterial hypertension. Ranexa can be used to treat chronic pain. AmBisome an antifungal agent for serious invasive fungal infections. The company also offers products under the names Emtriva and Hepsera as well as Tybost, Tybost, Tybost, Tybost, Tybost, Tybost, Tybost, Tybost, Tymost, Tybost, Tybost, Tybost, Tybost, Tybost, Tybost, Tybost. It also develops products for treating viral, inflammatory, and fibrotic conditions, as well as oncology. It markets products via its commercial teams and with its corporate partners and third-party distributors. Gilead Sciences, Inc. has agreements with Janssen Sciences Ireland UC, Bristol-Myers Squibb Company, Galapagos NV, Second Genome, Gadeta, Carna Biosciences Inc., Nurix Therapeutics, Inc., Humanigen, Inc., Kiniksa Pharmaceuticals, Ltd., Kyverna Therapeutics, Inc., Renown Institute for Health Innovation, Goldfinch Bio, Inc., Insitro, Inc., Novo Nordisk A/S, Kite Pharma, Inc. Roche Holding AG. To co-develop next-generation immunotherapies for cancer, the company is partnering with Arcus Biosciences, Inc. Gilead Sciences, Inc. is an American company that was established in 1987. Its headquarters are in Foster City, California.
Volume
Today's last reported volume for Gilead Sciences is 5133510, 39.82% below its average volume of 8530030.
Gilead Sciences's last close was $57.79, 22.03% below its 52-week high of $74.12.
Gilead Sciences's Sales
Gilead Sciences's sales growth is a negative 6% for the present quarter and a decline by 20.3% for the next. The company's growth estimates for the current quarter and the next is a negative 18.7% and a negative 42.6%, respectively.
Gilead Sciences's Revenue
Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 27.47B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Gilead Sciences's stock is considered to be overbought (>=80).
Gilead Sciences's Stock Yearly Top and Bottom Value
Gilead Sciences's stock is valued at $58.42 at 17:15 EST, way below its 52-week high of $74.12 and higher than its 52-week low of $57.19.
Gilead Sciences's Moving Average
Gilead Sciences's worth is under its 50-day moving average of $62.19 and way below its 200-day moving average of $66.02.More news about Gilead Sciences.
7. Invesco (IVZ) - Dividend Yield: 4.2%
Invesco Ltd., a public investment manager is owned by the company. It provides services for retail clients as well as institutional clients and high-net-worth clients. The firm manages client-specific equity and fixed income portfolios. It also offers equity, fixed income and commodity mutual funds to its clients. The firm launches fixed income, equity and multi-asset funds as well as balanced exchange-traded funds. It also manages and launches private funds. The firm invests in fixed and public equity markets around the world. It also invests in other markets such as currencies and commodities. It invests in large-cap, small-cap and mid-cap growth stocks. The firm also invests in fixed income, including convertibles, government bonds and municipal bonds. The firm also invests short-term and intermediate-term bonds, high-yield bonds, tax-free and taxable bonds, senior secured loans and structured securities like asset-backed security, commercial mortgage-backed Securities, and mortgage-backed Securities. It employs long/short, absolute return and global macro strategies. To make investments, it uses quantitative analysis. The company was previously known as Invesco plc.
Volume
Today's last reported volume for Invesco is 3350600, 20.73% below its average volume of 4227000.
Invesco's last close was $16.24, 44.67% under its 52-week high of $29.35.
Invesco's Sales
Invesco's sales growth is 7% for the present quarter and 3.2% for the next. The company's growth estimates for the current quarter and the next is a negative 13.4% and a negative 8.8%, respectively.
Invesco's Revenue
Year-on-year quarterly revenue growth declined by 1.8%, now sitting on 6.86B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Invesco's stock is considered to be overbought (>=80).
Invesco's Stock Yearly Top and Bottom Value
Invesco's stock is valued at $16.44 at 17:15 EST, under its 52-week low of $16.76.
Invesco's Moving Average
Invesco's worth is way under its 50-day moving average of $19.62 and way below its 200-day moving average of $22.57.More news about Invesco.
8. Radian Group (RDN) - Dividend Yield: 3.78%
Radian Group Inc. and its affiliates are involved in the United States' mortgage-related services industry. It operates two divisions, Mortgage Insurance and Services. The mortgage insurance segment provides credit-related insurance coverage. This includes private mortgage insurance for residential mortgage loans. It also offers other credit management solutions for mortgage lenders and investors in mortgage credit. The segment serves mortgage bankers and commercial banks as well as savings institutions, credit unions and credit unions. Services provides mortgage services. This includes transaction management services such as mortgage review, residential mortgage-backed security securitization, distressed asset reviews and review and valuation of single family rental property, servicer surveillance and underwriting, real estate management and brokerage, software as a platform solutions, and closing and title services. The segment offers its real estate and mortgage services to investors, mortgage lenders, financiers, governments, as well as other entities. Philadelphia is the headquarters of this company, which was established in 1977.
Volume
Today's last reported volume for Radian Group is 998326, 43.01% below its average volume of 1751710.
Radian Group's last close was $21.10, 15.06% below its 52-week high of $24.84.
The company's growth estimates for the current quarter and the next is 4% and 11.9%, respectively.Radian Group's Revenue
Year-on-year quarterly revenue growth declined by 8.5%, now sitting on 1.33B for the twelve trailing months.
Radian Group's Stock Yearly Top and Bottom Value
Radian Group's stock is valued at $21.10 at 17:15 EST, way below its 52-week high of $24.84 and way higher than its 52-week low of $19.17.
Radian Group's Moving Average
Radian Group's worth is under its 50-day moving average of $21.69 and under its 200-day moving average of $22.39.More news about Radian Group.
9. Consolidated Water Co. Ltd. (CWCO) - Dividend Yield: 2.97%
Consolidated Water Co. Ltd. and its subsidiaries design, build, manage, and operate water production and treatment plants, primarily in the Cayman islands, Bahamas and the United States. It operates in four business segments, including Bulk, Retail, Services and Manufacturing. Reverse osmosis is used to make potable water out of seawater. It supplies water to residential and commercial customers as well as to government-owned distributors. The company also offers design, engineering and construction services, procurement and management services, as well management and engineering services related to municipal water treatment and distribution. The company also manufactures and supplies a variety of water-related products such as reverse osmosis equipment, membrane separation apparatus, filtration equipment and vessels. It provides design, engineering and consulting services, in addition to inspection, management, maintenance, monitoring, testing, and training services. Consolidated Water Co. Ltd. is an entity that was established in 1973. Its headquarters are in Grand Cayman in the Cayman Islands.
Volume
Today's last reported volume for Consolidated Water Co. Ltd. is 81143, 10.51% below its average volume of 90671.
Consolidated Water Co. Ltd.'s last close was $14.34, 2.65% below its 52-week high of $14.73.
Consolidated Water Co. Ltd.'s Sales
Consolidated Water Co. Ltd.'s sales growth is 6% for the present quarter and 11.1% for the next. The company's growth estimates for the current quarter and the next is 33.3% and 209.1%, respectively.
Consolidated Water Co. Ltd.'s Revenue
Year-on-year quarterly revenue growth grew by 9.9%, now sitting on 66.86M for the twelve trailing months.
Consolidated Water Co. Ltd.'s Stock Yearly Top and Bottom Value
Consolidated Water Co. Ltd.'s stock is valued at $14.34 at 17:15 EST, below its 52-week high of $14.73 and way above its 52-week low of $9.01.
Consolidated Water Co. Ltd.'s Moving Average
Consolidated Water Co. Ltd.'s value is way above its 50-day moving average of $11.83 and way above its 200-day moving average of $11.11.More news about Consolidated Water Co. Ltd..
10. QUALCOMM (QCOM) - Dividend Yield: 2.22%
QUALCOMM Incorporated develops, produces, markets, and sells digital communication products around the world. The company operates in three segments, Qualcomm CDMA Technologies and Qualcomm Technology Licensing. QCT is a segment that develops integrated circuits and software for code division multiple acces (CDMA) and orthogonal frequency division multiple access (QTL), as well as other technologies. These include wireless voice and data, network, multi-media, global positioning systems products, programming, processing and networking. The QTL segment offers products for small cell implementation. QTL grants patent rights or licenses portions of its intellectual portfolio to wireless product manufacturers and sellers. This includes products that implement CDMA2000, CDMA wideband CDMA and CDMA time division doubleplex. QSI invests in companies at the early stages of their development in various sectors, such as artificial intelligence, automobile, digital healthcare and mobile networking. It also supports investment in new product and service designs for voice and data communication, new industries and segments. It also offers development and related services to US government agencies as well as their contractors. QUALCOMM Incorporated is located in San Diego, California.
Volume
Today's last reported volume for QUALCOMM is 6394920, 40.35% below its average volume of 10721400.
QUALCOMM's last close was $130.26, 32.71% under its 52-week high of $193.58.
The company's growth estimates for the present quarter and the next is 50% and 28.2%, respectively.QUALCOMM's Revenue
Year-on-year quarterly revenue growth grew by 40.7%, now sitting on 39.26B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,QUALCOMM's stock is considered to be overbought (>=80).
QUALCOMM's Stock Yearly Top and Bottom Value
QUALCOMM's stock is valued at $130.79 at 17:15 EST, way below its 52-week high of $193.58 and above its 52-week low of $122.17.
QUALCOMM's Moving Average
QUALCOMM's value is under its 50-day moving average of $138.64 and way below its 200-day moving average of $154.46.More news about QUALCOMM.